Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

Identification of MCM family as potential therapeutic and prognostic targets for hepatocellular carcinoma based on bioinformatics and experiments

(2021) Yu Lei et al.   LIFE SCIENCES

NUP37 silencing induces inhibition of cell proliferation, G1 phase cell cycle arrest and apoptosis in non-small cell lung cancer cells

(2020) Lianglong Huang et al.   PATHOLOGY RESEARCH AND PRACTICE

Epigenetic Therapies for Cancer

(2020) Susan E. Bates   NEW ENGLAND JOURNAL OF MEDICINE

Identification of the DNA Replication Regulator MCM Complex Expression and Prognostic Significance in Hepatic Carcinoma

(2020) Ting Cao et al.   Biomed Research International

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

(2019) Andrew X Zhu et al.   LANCET ONCOLOGY

Hepatocellular Carcinoma

(2019) Augusto Villanueva   NEW ENGLAND JOURNAL OF MEDICINE

Expression of the type 3 InsP3 receptor is a final common event in the development of hepatocellular carcinoma

(2019) Mateus T Guerra et al.   GUT

Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma

(2019) Qiang Gao et al.   CELL

Deletion of low-density lipoprotein-related receptor 5 inhibits liver Cancer cell proliferation via destabilizing Nucleoporin 37

(2019) Jinxiao Chen et al.   Cell Communication and Signaling

Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial

(2019) Richard S. Finn et al.   JOURNAL OF CLINICAL ONCOLOGY

OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism

(2019) W.Q. Dai et al.   JOURNAL OF HEPATOLOGY

Molecular therapies and precision medicine for hepatocellular carcinoma

(2018) Josep M. Llovet et al.   Nature Reviews Clinical Oncology

MCM2 promotes symmetric inheritance of modified histones during DNA replication

(2018) Nataliya Petryk et al.   SCIENCE

MCM2: An alternative to Ki-67 for measuring breast cancer cell proliferation

(2017) Einas M Yousef et al.   MODERN PATHOLOGY

NUP37, a positive regulator of YAP/TEAD signaling, promotes the progression of hepatocellular carcinoma

(2017) Xiaoling Luo et al.   Oncotarget

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

(2015) Kornelius Schulze et al.   NATURE GENETICS

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data

(2015) Antonio Colaprico et al.   NUCLEIC ACIDS RESEARCH

Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays

(2014) Martin J. Aryee et al.   BIOINFORMATICS

Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

(2014) Yasushi Totoki et al.   NATURE GENETICS

Concise Drug Review: Azacitidine and Decitabine

(2013) E. J. B. Derissen et al.   ONCOLOGIST